Angiotensin in Septic Kidney Injury Trial

PHASE2UnknownINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

February 28, 2013

Conditions
Acute Renal FailureSepsisSeptic Shock
Interventions
DRUG

Angiotensin II

Angiotensin II will be given by continuous infusion for 24 hours starting at a dose of 5ng/kg/min and then titrated to a maximum dose of 15 ng/kg/min according to a blood pressure based protocol

DRUG

Saline placebo

Saline placebo will be given by continuous infusion according to a blood-pressure base protocol. This protocol will also incorporate noradrenaline for blood pressure control (as is true in the active drug arm), such that blood pressure targets will be rapidly achieved in both arms of the study; the only difference being that in the active drug arm, at least part of the pressor effect will be provided by angiotensin II.

Trial Locations (2)

3011

RECRUITING

The Western Hospital, Footscray

3074

RECRUITING

Northern Hospital, Epping

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Northern Health and Social Care Trust

OTHER_GOV

collaborator

Western Hospital, Australia

OTHER_GOV

lead

Austin Health

OTHER_GOV

NCT00711789 - Angiotensin in Septic Kidney Injury Trial | Biotech Hunter | Biotech Hunter